Home >> WP3

Developing therapeutic strategies targeting regulatory circuitries in CPs

WP3 will define the aberrant regulatory circuitry inferred through multivariate analyses; to test the functional relevance of these regulatory elements in CPs for the identification of novel and specific therapeutic targets, suitable for drug treatment; to define the efficacy of selected drugs targeting the chromatin regulators and mechano-signalling using in vitro and in vivo diseases models for CPs

By using the site, you agree to our use of cookies. More info

This site uses cookies to provide the best browsing experience possible. By continuing to use this site without changing your cookie settings or by clicking on "Accept" you allow their use.